Back to Search Start Over

Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer

Authors :
Jean-Pierre Gerard
Lucile Montagne
Brice Thamphya
Jerôme Doyen
Renaud Schiappa
Karene Benezery
Sophie Gourgou
Catherine Dejean
Jean-Michel Hannoun-Levi
Source :
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 70-76 (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Introduction: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. Material and methods: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. Results: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. Conclusion: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option.

Details

Language :
English
ISSN :
24056308
Volume :
33
Issue :
70-76
Database :
Directory of Open Access Journals
Journal :
Clinical and Translational Radiation Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.43b88a4daf3b4ce29fc68a738635b243
Document Type :
article
Full Text :
https://doi.org/10.1016/j.ctro.2021.12.007